Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032390	u-jcvnh	— (—)	203	781	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

143

117.97

275.88

4.2

2.4

—

L04AA Selective immunosuppressants

136

91.85

260.00

4.0

2.8

—

Renal failure

148

87.75

251.91

4.1

2.7

—

All chronic kidney diseases

153

59.86

230.89

4.2

3.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

171

65.65

213.38

4.0

2.1

—

All kidney diseases

161

32.43

185.47

4.1

2.7

—

ILD medications: immunosuppressive drugs

189

252.97

179.52

4.0

1.0

—

L04AD Calcineurin inhibitors

175

259.87

171.79

4.0

6.0

—

Renal tubulo-interstitial diseases

144

24.99

165.40

3.9

3.5

—

First line medication for Crohn's disease

159

57.39

164.91

4.5

2.1

—

Glomerular diseases

42.67

162.15

4.2

4.5

—

Nephropathy related operations

153

263.13

150.18

4.3

3.0

—

Kidney transplant status

146

261.81

144.18

4.3

3.0

—

Dialysis, with operation codes

146

250.04

142.88

4.1

3.0

—

Azathioprine

37.39

137.37

5.4

3.7

—

ILD medications

174

118.15

127.76

4.3

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

164

114.89

121.75

4.3

1.0

—

Hypoplasia of dental enamel

55.64

119.97

6.7

5.9

—

Molar incisor enamel hypoplasia

38.08

117.49

6.6

5.9

—

L04AX Other immunosuppressants

16.27

117.20

5.2

2.6

—

Second line medication for Crohn's disease

100

15.91

117.05

5.2

2.5

—

Glomerulonephritis

41.25

114.17

5.3

5.1

—

Hypoplasia of dental enamel , including avohilmo

35.13

110.93

6.7

5.9

—

Care involving dialysis

111

143.55

104.76

3.9

3.8

—

Acute tubulo-interstitial nephritis

24.14

102.63

4.0

3.5

—

Fever of other and unknown origin

18.93

102.58

3.8

2.2

—

Persons encountering health services for specific procedures and health care

130

13.94

102.36

3.9

3.6

—

Nephrotic syndrome

55.37

101.89

5.9

6.7

—

Gingival hyperplasia

54.05

99.71

6.5

5.5

—

Dialysis

206.88

94.51

4.8

2.8

—

Septicaemia

17.39

89.09

4.3

—

Other septicaemia

18.03

86.13

4.0

4.4

—

Explicit Sepsis

15.81

84.99

4.3

4.8

—

Hypertensive diseases (excluding secondary)

20.49

84.74

5.0

3.8

—

Antihypertensive medication - note that there are other indications

103

18.24

82.41

5.3

3.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

11.07

82.29

4.5

3.0

—

Other disorders of kidney and ureter

44.01

80.53

4.1

—

Hypertensive diseases

104

14.70

80.37

4.7

3.1

—

Hypertension

104

14.70

80.36

4.7

3.1

—

Other bacterial diseases

111

10.23

80.02

4.0

3.6

—

Other problems related to primary support group, including family circumstances

17.21

75.13

7.1

4.3

—

Other bacterial diseases

112

9.12

72.61

4.0

3.6

—

Intestinal infectious diseases

101

9.13

72.47

4.1

2.8

—

Dental caries

95.51

70.70

3.8

1.5

—

Extracorporeal dialysis

95.52

67.29

3.5

4.8

—

Cardiovascular diseases (excluding rheumatic etc)

11.52

67.09

5.0

4.3

—

Viral infections characterized by skin and mucous membrane lesions

10.16

65.94

4.5

4.3

—

Genitourinary diseases

18.56

65.58

5.7

3.7

—

Viral and other specified intestinal infections

14.84

65.52

5.6

3.7

—

Bacterial infection, other or unspecified

14.04

63.36

3.7

3.4

—

Congenital malformations of the urinary system

17.95

62.88

4.3

6.2

—

Congenital malformations of the urinary system

17.93

62.87

4.3

6.2

—

Viral and other specified intestinal infections

13.12

62.85

5.5

4.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

11.51

62.64

6.9

3.5

—

Bacterial infection, other or unspecified

12.60

59.74

3.7

3.4

—

Anaemias

34.06

58.25

4.8

4.5

—

Other dialysis

84.85

57.60

4.9

4.8

—

Cardiovascular diseases

10.89

56.51

5.1

4.6

—

Inflammatory bowel disease treatment related agents

108

7.28

55.79

4.8

2.7

—

Caries of dentine

96.17

53.19

2.9

1.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6.98

53.01

4.1

3.6

—

Heart failure, not strict

10.49

52.35

2.5

4.0

—

Molar incisor enamel hypoplasia, with caries

79.08

52.28

6.6

7.8

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

52.05

6.0

0.0

—

GASTRO-related operations

43.53

49.79

4.3

2.4

—

Any gastric operation

43.53

49.79

4.3

2.4

—

Aplastic and other anaemias

11.90

48.65

3.6

3.1

—

Viral infections characterized by skin and mucous membrane lesions

111

6.48

48.52

4.0

3.6

—

Acute upper respiratory infections of multiple and unspecified sites

9.01

47.79

4.0

2.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

14.53

46.74

3.2

5.3

—

Certain infectious and parasitic diseases

13.78

45.64

3.8

1.9

—

Other viral diseases

7.50

44.26

5.4

4.1

—

Metabolic disorders

6.94

43.40

2.9

4.2

—

Other viral diseases

6.92

41.80

5.4

4.0

—

Care involving use of rehabilitation procedures

9.79

41.70

3.6

3.9

—

Gastrointestinal diseases

22.80

40.98

4.6

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

6.51

40.78

4.1

2.6

—

Implicit bacterial Sepsis

16.42

40.69

3.0

3.8

—

Bacterial Sepsis

12.15

40.45

3.5

4.0

—

Disorders resulting from impaired renal tubular function

77.65

40.13

4.1

4.7

—

Implicit viral Sepsis

13.13

39.91

3.5

3.8

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.52

39.61

4.2

5.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.51

39.53

4.2

5.9

—

Implicit Sepsis

8.25

39.32

2.8

3.6

—

9.01

38.30

3.6

2.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9.01

38.30

3.6

2.2

—

Implicit Sepsis

7.84

37.88

2.9

3.5

—

Influenza and pneumonia

105

5.33

37.17

3.8

3.7

—

Liquid cancers, helper endpoint

9.83

36.61

3.0

4.7

—

Congenital malformations, deformations and chromosomal abnormalities

6.13

36.14

3.5

4.0

—

Implicit bacterial Sepsis

13.33

36.04

3.0

3.5

—

Glomerular disorders in diseases classified elsewhere

52.92

35.40

2.1

3.0

—

Excessive attrition of teeth

6.34

34.47

6.1

2.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

7.06

34.31

2.9

3.4

—

All influenza

9.13

33.83

4.6

4.9

—

Disorders of other endocrine glands

6.30

32.84

5.1

4.8

—

Infections, IBD-co-morbidities

18.19

32.78

2.8

5.0

—

Congenital malformations, deformations and chromosomal abnormalities

102

5.61

32.13

3.6

3.8

—

Nausea and vomiting

7.41

31.78

5.0

5.1

—

Codes for special purposes

6.71

31.25

3.4

3.8

—

Provisional assignment of new diseases of uncertain etiology

6.71

31.25

3.4

3.8

—

Other viral diseases, not elsewhere classified

6.72

29.97

5.9

4.5

—

Any reimbursement code in KELA

39.31

29.72

3.7

1.5

—

Cystic kidney disease

67.69

29.03

3.0

4.0

—

Cystic kidney disease

67.55

29.02

3.0

4.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

5.98

28.95

2.9

3.4

—

Intestinal infectious diseases

5.21

28.81

3.8

2.6

—

Bronchitis

5.75

28.59

3.5

2.0

—

General examination and investigation of persons without complaint and reported diagnosis

10.68

28.47

4.6

1.4

—

Other viral diseases, not elsewhere classified

5.96

27.81

5.9

4.4

—

Covid-19 confirmed case

7.88

27.21

3.2

3.1

—

Other reaction to severe stress, and adjustment disorders

7.37

27.09

3.5

3.0

—

Pneumonias (Asthma/COPD co-morbidities)

113

4.46

26.85

3.7

4.0

—

Erosion of teeth , including avohilmo

7.47

26.69

5.7

3.2

—

Pneumonia, organism unspecified

101

4.72

26.45

3.9

3.8

—

Anomalies of dental arch relationship, including avohilmo

7.51

26.29

6.2

3.8

—

Diabetic nephropathy

51.22

26.03

1.1

1.2

—

Other and unspecified anaemias

8.32

25.56

3.4

3.2

—

Viral warts

7.80

25.49

4.9

3.9

—

Diseases of peritoneum

58.36

24.99

3.5

2.0

—

Other anaemias

8.09

24.97

3.4

3.1

—

Zoster [herpes zoster]

8.52

24.87

2.1

2.2

—

All pneumoniae

120

4.18

24.84

3.7

4.0

—

Implicit viral Sepsis

21.25

24.69

3.6

4.4

—

Viral Sepsis

21.25

24.69

3.6

4.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

5.11

24.62

5.6

4.3

—

Diabetic nephropathy, excluding more controls

51.21

24.61

1.1

1.0

—

General symptoms and signs

6.06

24.59

3.2

2.0

—

Certain disorders involving the immune mechanism

8.81

23.27

5.2

3.7

—

Other retinal disorders

6.91

23.01

1.6

2.7

—

Other disorders of urethra and urinary system

5.93

22.91

4.0

3.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

123

3.99

22.74

3.7

3.9

—

Crowding of teeth, including avohilmo

6.63

22.71

6.8

5.3

—

Complications of medical and surgical care

5.45

22.69

2.7

2.8

—

Hypoplasia of dental enamel, prenatal

64.23

22.35

8.0

5.7

—

Endocrine, nutritional and metabolic diseases

4.91

22.20

3.8

4.7

—

Acute suppurative otitis media

6.41

22.03

5.3

4.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

8.98

22.00

4.1

1.4

—

Complications of surgical and medical care, not elsewhere classified

4.62

21.88

2.7

3.0

—

Other cataract

10.76

21.54

4.0

2.7

—

Examination and observation for other reasons

9.37

21.35

4.2

1.2

—

Otitis media, unspecified

7.55

21.17

4.8

5.2

—

Certain infectious and parasitic diseases

9.27

21.13

4.0

1.8

—

Acute upper respiratory infections

5.01

20.49

4.0

2.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.09

20.01

3.4

3.9

—

Viral warts

17.34

19.98

5.2

5.4

—

Disorders of lens

6.78

19.86

3.2

2.1

—

Other disorders of fluid, electrolyte and acid-base balance

15.26

19.46

3.5

4.1

—

Other disorders of skin and subcutaneous tissue

5.31

19.41

2.6

3.3

—

Medical observation and evaluation for suspected diseases and conditions

8.14

18.71

3.4

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.69

18.45

2.6

2.9

—

COPD/asthma related infections

5.62

18.36

3.8

2.2

—

COPD/asthma/ILD related infections

5.62

18.36

3.8

2.2

—

Caries of enamel

4.06

17.86

4.8

2.5

—

Other diseases of hard tissues of teeth

11.65

17.75

5.3

1.6

—

Persons encountering health services in other circumstances, wide

3.82

17.74

3.5

3.9

—

Speech and linguistic disorders, excluding more controls

7.10

17.66

6.3

5.2

—

Polycystic kidney disease

37.45

17.66

2.5

5.2

—

Hypoplasia of dental enamel, prenatal , including avohilmo

22.35

17.49

8.0

6.6

—

Headache

6.24

17.48

3.9

2.1

—

Disorders of choroid and retina

5.03

17.27

1.6

2.6

—

Neoplasms

3.82

16.90

4.0

4.5

—

Symptoms and signs involving the urinary system

4.40

16.76

3.9

3.4

—

Unspecified haematuria

7.00

16.59

4.4

2.7

—

Other acute lower respiratory infections

103

4.07

16.02

4.3

4.2

—

Suppurative and unspecified otitis media

5.01

15.97

5.2

3.6

—

Certain conditions originating in the perinatal period

5.26

15.83

5.6

5.3

—

Other heart diseases

5.58

15.80

4.2

4.4

—

Hypertension, essential

6.44

15.78

1.4

1.8

—

Diabetic retinopathy

9.36

15.74

1.3

—

Other endocrine disorders

5.73

15.58

6.3

6.8

—

4.43

15.44

4.0

2.1

—

Nonsuppurative otitis media

5.65

15.41

4.6

4.5

—

Disorders of refraction and accommodation

4.44

14.81

6.4

4.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

25.10

14.67

2.3

2.0

—

Personal history of other diseases and conditions

35.95

14.39

4.6

1.2

—

Other metabolic disorders

13.38

14.17

3.2

3.4

—

Crossbite

4.81

14.10

6.2

6.5

—

Lack of expected normal physiological development

20.81

14.09

5.5

4.9

—

Heart failure and antihypertensive medication

27.50

13.90

3.4

1.0

—

Melanocytic naevi

6.01

13.83

4.1

3.4

—

Hypo-osmolality and hyponatraemia

23.65

13.72

3.6

3.9

—

Cytomegalovirus infection, IBD co-morbidity

34.65

13.54

3.2

4.4

—

4.74

13.37

6.7

6.4

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

18.24

13.34

1.8

2.7

—

Symptoms and signs concerning food and fluid intake

21.15

13.30

7.2

4.1

—

Persons with potential health hazards related to communicable diseases

106

3.75

13.17

5.0

4.8

—

Insulin, fast-acting (human)

12.14

13.06

1.2

2.8

—

Deep bite

4.55

13.03

6.6

5.7

—

Type 1 diabetes

4.39

13.02

1.5

5.4

—

Infections of the skin and subcutaneous tissue

126

3.46

12.92

4.3

4.1

—

Other disorders starting during childhood or adolecense, excluding more controls

6.24

12.89

8.1

5.5

—

Zoster [herpes zoster]

14.03

12.72

2.2

2.8

—

Diseases of middle ear and mastoid

3.94

12.69

4.5

3.1

—

Diseases of the eye and adnexa

3.63

12.57

4.2

4.0

—

Persons encountering health services for examination and investigation

6.38

12.50

3.1

1.4

—

Diabetic retinopathy, strict definition

14.30

12.46

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

4.58

12.32

1.4

2.4

—

Sub-endpoint used in defining T1D endpoints

4.20

12.30

1.5

5.2

—

Anxiety disorders, excluding more controls

3.74

12.17

4.2

2.3

—

Malignant neoplasm

3.41

12.07

2.9

3.6

—

Neurotic, stress-related and somatoform disorders

102

3.29

11.88

3.9

2.9

—

Malignant neoplasm, wide definition for exclusion

3.29

11.87

2.9

3.7

—

Diabetic retinopathy, excluding more controls

15.44

11.82

1.4

1.3

—

Anxiety disorders

102

3.28

11.80

3.9

2.9

—

4.57

11.64

7.1

6.5

—

Disorders of psychological development

3.97

11.23

5.7

—

Other pulmonary diagnosis

5.18

11.22

3.0

2.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.67

10.92

5.7

4.7

—

Coagulation defects, purpura and other haemorrhagic conditions

5.39

10.86

3.7

4.9

—

Bleeding

3.26

10.82

2.6

3.7

—

Acute bronchiolitis

4.18

10.74

5.5

6.0

—

Insulin, fast-acting

4.03

10.63

1.4

5.3

—

Other bacterial intestinal infections

12.88

10.62

2.3

3.3

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

19.63

10.61

1.1

2.2

—

Short stature, not elsewhere classified

4.83

10.56

6.1

6.9

—

Excluding asthma or asthma-COPD overlap

5.01

10.52

3.1

2.1

—

COPD differential diagnosis

5.01

10.52

3.1

2.0

—

ILD differential diagnosis

5.01

10.52

3.1

2.0

—

Other diseases of urinary system

3.01

10.48

4.1

3.4

—

Polyneuropathies and other disorders of the peripheral nervous system

10.02

10.48

2.4

3.0

—

Insulin, fast-acting or short human

3.97

10.44

1.4

5.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

16.22

10.36

6.4

—

Other disorders involving the immune mechanism, not elsewhere classified

16.20

10.36

6.4

—

Hypermetropia

7.71

10.36

6.4

—

Other and unspecified tonsillitis

4.81

10.34

4.7

2.8

—

Osteopathies and chondropathies

3.88

10.28

2.9

3.6

—

Diabetic maculopathy, excluding more controls

18.80

10.25

1.1

1.4

—

Agranulocytosis

13.12

10.14

5.7

3.3

—

Convulsions, not elsewhere classified

9.41

10.13

4.8

3.0

—

Tooth eruption problems

4.12

10.13

5.0

4.8

—

Mycoses

5.27

10.09

3.7

3.6

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

14.82

10.03

6.6

6.4

—

Diabetic maculopathy

22.03

9.91

1.1

1.2

—

Vitreous haemorrhage

26.07

9.80

1.2

1.0

—

Acute sinusitis

4.74

9.64

3.1

1.9

—

Statin medication

4.00

9.60

2.0

2.4

—

Heart failure,strict

8.72

9.50

3.4

3.8

—

Other bacterial intestinal infections

10.01

9.49

2.3

3.0

—

Hyperlipidaemia, other/unspecified

10.36

9.49

1.5

1.6

—

Dentofacial anomalies [including malocclusion]

3.39

9.49

5.2

2.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

9.38

3.4

0.0

—

Disorders of parathyroid gland

21.43

9.28

2.0

—

Malaise and fatigue

5.19

9.22

2.1

2.5

—

Tramadol

4.20

9.22

1.6

1.3

—

Cough

3.66

9.22

4.6

4.3

—

Erysipelas

5.25

9.18

1.3

1.4

—

Oedema, not elsewhere classified

8.89

8.91

2.6

1.6

—

Symptoms and signs involving the skin and subcutaneous tissue

109

3.14

8.91

3.3

3.8

—

Other and unspecified polyneuropathies, also in other diseases

12.52

8.85

1.7

2.3

—

Hyperparathyroidism

23.74

8.85

2.0

1.2

—

Any event in cancer register

2.88

8.81

3.1

3.5

—

Dermatitis

3.36

8.81

4.2

3.1

—

Type 1 diabetes, wide definition

3.77

8.74

1.4

5.4

—

Irregular menses

4.74

8.73

2.1

1.9

—

Otitis externa

4.38

8.60

6.0

4.3

—

Bacterial intestinal infections, IBD co-morbidities

8.20

8.55

2.3

4.0

—

Speech and linguistic disorders

3.55

8.54

6.3

5.9

—

Heart failure, strict

4.78

8.45

3.4

2.6

—

All influenza (not pneumonia)

7.32

8.42

5.3

4.9

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

9.50

8.28

6.0

6.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.68

8.20

1.9

3.5

—

Non-Hodgkin lymphoma, all, including Hilmo

14.47

8.19

2.0

3.8

—

Senile cataract

5.11

8.14

1.2

1.4

—

Erysipelas

4.31

8.11

1.5

1.4

—

Need for other prophylactic measures

11.73

8.07

7.0

6.3

—

Peripheral artery operations in Hilmo

22.02

8.00

1.1

1.0

—

Other strabismus

3.74

8.00

5.4

5.0

—

Gout, FINNGEN

9.98

8.00

1.7

1.3

—

All-cause Heart Failure

4.71

7.93

3.5

2.7

—

Other and unspecified dermatitis

3.42

7.92

4.5

3.2

—

Hernia

105

2.75

7.90

5.0

3.3

—

Peripheral artery disease

8.46

7.89

1.1

1.3

—

Other diseases of blood and blood-forming organs, wide

6.07

7.82

5.6

3.7

—

Symptoms and signs involving the digestive system and abdomen

2.64

7.82

4.9

3.9

—

Neurological diseases, wide definition

4.62

7.76

4.5

4.8

—

Type 1 diabetes, wide definition, subgroup 1

3.64

7.70

1.1

5.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.73

7.57

7.8

5.6

—

Other heart diseases, wide

122

2.51

7.56

3.8

—

Rare circulating lymphoid malignancy, including Hilmo

10.10

7.54

4.5

6.1

—

Melanocytic naevi of trunk

10.02

7.52

4.1

2.6

—

Strabismus

3.29

7.46

5.1

—

Retinal haemorrhage

+∞

7.30

1.9

0.0

—

Other postsurgical states

+∞

7.29

5.9

0.0

—

Type 2 diabetes, wide definition

3.53

7.29

1.2

—

Volume depletion

10.86

7.29

3.8

4.6

—

Recurrent aphthous stomatitis , including avohilmo

6.81

7.27

5.9

4.4

—

Cellulitis

4.14

7.26

4.6

4.3

—

Acute bronchitis

3.31

7.24

3.5

4.4

—

Diseases of oral cavity, salivary glands and jaws

7.72

7.13

3.6

1.6

—

Gout

8.25

7.09

1.7

1.3

—

Invasive ventilation

12.04

7.07

6.3

5.0

—

12.02

7.07

2.3

2.6

—

Other medical care

6.65

7.03

3.4

3.2

—

Varicella [chickenpox]

10.06

7.03

4.4

4.8

—

Diseases of pulp and periapical tissues and dental caries

3.64

7.01

4.3

3.9

—

Congenital vesicoureteral reflux

14.32

6.96

7.2

6.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.95

6.82

1.4

4.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.31

6.79

6.2

6.7

—

Lymphoid leukaemia

9.33

6.78

4.8

5.9

—

Diabetic neuropathy

10.88

6.76

1.1

1.2

—

Open bite

4.27

6.75

5.5

6.3

—

Diseases of arteries, arterioles and capillaries

3.61

6.74

1.0

1.9

—

Bacterial pneumoniae

3.99

6.70

2.9

3.4

—

Enterocolitis due to Clostridium difficile

12.25

6.57

2.7

2.8

—

Acute pharyngitis

5.82

6.54

6.6

3.5

—

Hyperkinetic disorders, excluding more controls

5.39

6.48

6.2

5.2

—

Childhood asthma (age<16)

9.32

6.46

3.2

3.7

—

Childhood asthma (age<16), excluding more controls

9.32

6.46

3.2

3.7

—

Viral pneumonia

7.38

6.40

2.5

4.3

—

Diseases of external ear

3.39

6.40

5.9

4.2

—

Cutaneous abscess, furuncle and carbuncle

4.05

6.34

3.1

3.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

118

2.32

6.31

2.8

4.3

—

Bacterial pneumonia, not elsewhere classified

3.96

6.30

2.7

3.2

—

Immunodeficiency with predominantly antibody defects

18.14

6.27

4.4

6.2

—

Other diseases of arteries and capillaries

18.04

6.26

1.1

1.8

—

Acute nephritic syndrome

+∞

6.26

3.5

0.0

—

Diseases of the respiratory system

3.94

6.25

3.7

2.1

—

Hypothyroidism (congenital or acquired)

8.79

6.20

2.6

4.3

—

Disorders of skin appendages

2.99

6.19

4.1

3.4

—

Otitis externa, unspecified

6.27

6.15

5.7

4.5

—

Autoimmune diseases excluding thyroid diseases

119

2.29

6.15

2.8

4.3

—

Nutritional anaemias

3.37

6.03

4.4

3.5

—

Immunodeficiencies

10.05

6.03

3.8

4.5

—

Exclusions for E4_PCOS_BROAD

3.24

5.98

6.0

5.4

—

Cerebrovascular diseases (FINNGEN)

8.36

5.98

2.5

1.4

—

Opioids

2.93

5.95

1.8

1.9

—

Drug-induced polyneuropathy

15.38

5.93

3.7

6.7

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.69

5.87

3.9

1.3

—

Varicella [chickenpox]

6.39

5.85

4.1

5.8

—

Diseases of the skin and subcutaneous tissue

2.51

5.79

3.9

3.5

—

Other disorders starting during childhood or adolescence

3.18

5.77

8.1

5.9

—

Oxycodone

5.36

5.76

1.6

1.3

—

Dental caries, including avohilmo

3.05

5.71

4.2

3.4

—

Insulin medication

2.69

5.71

1.4

4.3

—

Other congenital malformations of the digestive system

3.60

5.70

5.9

6.7

—

Venous thromboembolism

4.83

5.66

1.7

1.3

—

Tonsillectomy and adenotomy

118

2.36

5.62

5.4

4.2

—

Polycystic ovarian syndrome, consortium definition

3.43

5.61

2.1

1.9

—

Overjet

3.72

5.61

7.8

6.1

—

Coronary atherosclerosis

3.93

5.60

1.1

1.2

—

Other noninfective gastroenteritis and colitis

3.10

5.59

3.9

5.1

—

Peripheral arterial reconstruction

12.87

5.57

1.1

1.0

—

Iron deficiency anaemia

3.41

5.57

4.5

3.7

—

Insulin, intermediate and long-acting

2.81

5.55

1.2

4.3

—

Disorders of sclera, cornea, iris and ciliary body

2.99

5.51

2.3

3.0

—

Actinic keratosis

8.49

5.48

1.0

1.1

—

Asthma

3.75

5.47

2.6

2.1

—

Stomatitis and related lesions

4.60

5.47

5.9

3.7

—

7.34

5.46

1.2

1.6

—

Asthma, excluding more controls

3.73

5.43

2.6

2.1

—

Intermittent heterotropia

4.87

5.42

5.7

6.8

—

Abnormal findings on examination of urine, without diagnosis

16.07

5.41

1.9

5.0

—

Distal bite

3.47

5.40

8.1

6.1

—

Other disorders of bone

5.18

5.38

3.5

2.8

—

Non-ischemic cardiomyopathy

5.93

5.37

4.5

3.2

—

STROKE

3.71

5.35

1.8

2.5

—

Any death

3.27

5.33

1.7

2.0

—

Non-follicular lymphoma

11.27

5.29

2.2

2.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

6.43

5.28

1.1

1.3

—

Cystitis

2.61

5.28

3.7

3.5

—

Medullary cystic kidney disease, nephronophthisis

+∞

5.27

3.8

0.0

—

Specific development disorders of scholastic skills

3.69

5.25

6.1

—

Candidiasis

6.68

5.24

3.6

4.2

—

Skin changes due to chronic exposure to nonionizing radiation

7.80

5.24

1.0

1.1

—

Herpesviral [herpes simplex] infections

5.39

5.21

4.1

2.3

—

Used for control exclusion in common control thyroid runs

118

2.14

5.20

3.9

4.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.79

5.11

5.4

—

Asthma (only as main-diagnosis)

3.72

5.09

2.8

2.1

—

Other embolism and thrombosis

13.35

5.07

2.0

1.5

—

Seborrhoeic keratosis

13.34

5.07

1.8

2.2

—

Noninflammatory disorders of female genital tract

4.06

5.05

3.1

2.7

—

Bacterial pneumonia (organism specified)

3.02

5.03

2.9

3.6

—

Disorders of gallbladder, biliary tract and pancreas

2.48

5.03

3.5

2.1

—

Hypothyroidism, levothyroxine purchases

7.54

4.99

2.6

4.3

—

Hypothyroidism and >3 levothyroxin purchases

7.54

4.99

2.6

4.3

—

Asthma (only as main-diagnosis), excluding more controls

3.68

4.99

2.8

2.1

—

Excessive, frequent and irregular menstruation

4.33

4.95

2.7

2.3

—

Glaucoma

4.44

4.92

1.5

—

Complications of procedures, not elsewhere classified

2.72

4.90

2.2

2.8

—

Bacterial, viral and other infectious agents

7.71

4.84

6.1

4.5

—

Asthma (mode)

3.51

4.84

2.2

2.0

—

Polyuria

7.70

4.84

1.7

1.9

—

Inguinal hernia

2.60

4.78

5.8

3.3

—

Gout, unspecified

9.01

4.78

2.1

1.3

—

Keratitis

3.27

4.74

2.6

3.2

—

Other diseases of lip and oral mucosa

3.27

4.74

4.9

2.9

—

Any mental disorder

2.25

4.69

4.2

2.8

—

Disorders of vitreous body

4.39

4.69

1.2

1.4

—

Codeine

2.90

4.66

1.6

1.3

—

Visual disturbances and blindness

2.64

4.63

3.6

4.3

—

Pain, not elsewhere classified

6.11

4.59

2.4

2.3

—

Other congenital malformations of the digestive system

3.10

4.57

5.9

6.7

—

Other necrotizing vasculopathies

14.03

4.57

3.4

2.6

—

Special screening examination for other diseases and disorders

14.01

4.57

2.4

1.8

—

Herpesviral [herpes simplex] infections

8.19

4.56

5.3

2.1

—

Enlarged lymph nodes

8.19

4.55

4.8

2.5

—

Congenital malformations and deformations of the musculoskeletal system

2.89

4.54

5.8

6.3

—

All anxiety disorders

2.57

4.54

3.5

3.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.38

4.53

2.4

1.3

—

Acute laryngitis and tracheitis

5.37

4.53

6.1

4.4

—

Explicit bacterial Sepsis

10.01

4.51

5.6

5.4

—

Dental operations

4.06

4.50

3.0

1.4

—

Diseases of the musculoskeletal system and connective tissue

2.21

4.50

4.5

5.0

—

Bacterial, viral and other infectious agents

6.68

4.46

6.1

4.7

—

Rash and other nonspecific skin eruption

6.68

4.46

5.0

5.2

—

Speech therapy

4.38

4.42

3.6

3.2

—

Embedded and impacted teeth

2.75

4.41

4.4

4.3

—

Covid-19 suspected case

4.06

4.39

4.7

3.4

—

Congenital malformations and deformations of the musculoskeletal system

2.92

4.39

5.7

6.5

—

Viral pneumonia (unknown virus, not influenza)

7.52

4.35

2.8

4.5

—

Diseases of oesophagus, stomach and duodenum

109

2.14

4.30

1.7

3.6

—

Atrial fibrillation and flutter

7.21

4.28

1.2

1.4

—

Abnormalities of breathing

102

2.16

4.28

3.3

3.4

—

Undetermined asthma, excluding more controls

8.89

4.27

3.4

2.9

—

Undetermined asthma

8.89

4.27

3.4

2.9

—

Other disorders of bladder

11.68

4.27

1.0

1.8

—

Disorders of vitreous body and globe

3.89

4.21

1.2

1.6

—

Gout, idiopatic and unspecified

6.93

4.16

2.1

1.2

—

In situ neoplasms

5.24

4.13

1.3

1.1

—

Amblyopia ex anopsia

4.36

4.13

5.0

6.8

—

Gingivitis and periodontal diseases

2.17

4.07

3.9

4.0

—

Thrombocytopenia, unspecified

8.02

4.06

6.0

5.9

—

Chronic pancreatitis

8.01

4.06

1.9

1.8

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.68

4.04

6.4

6.7

—

Other and unspecified drugs and medicaments

10.02

4.01

3.3

2.1

—

Streptococcal septicaemia

10.02

4.01

6.1

5.3

—

Autoimmune diseases

122

1.96

3.99

3.2

4.3

—

Other anxiety disorders

2.79

3.98

2.6

2.9

—

Diseases of the ear and mastoid process

100

2.06

3.95

4.0

2.5

—

Purpura and other haemorrhagic conditions

4.45

3.93

4.7

5.6

—

Hernia of abdominal wall

2.88

3.89

5.1

2.3

—

Symptoms and signs involving the circulatory and respiratory systems

104

2.02

3.88

4.5

3.4

—

Delayed milestone in childhood

2.76

3.85

5.8

7.4

—

Pruritus

6.01

3.81

2.0

2.8

—

Astigmatism

4.29

3.81

7.7

6.6

—

Abdominal and pelvic pain

2.06

3.79

5.0

3.9

—

Systemic connective tissue disorders

3.94

3.78

2.7

2.9

—

Other benign neoplasms of skin

3.69

3.78

2.1

2.6

—

6-mercaptopurine

12.04

3.76

3.3

7.6

—

Neuromuscular dysfunction of bladder

12.02

3.76

2.2

2.0

—

Benign neoplasm: Skin of other and unspecified parts of face

12.01

3.76

1.0

—

Benign neoplasms

106

2.03

3.73

3.4

3.3

—

Pain (limb, back, neck, head abdominally)

2.10

3.66

4.6

4.3

—

Non-allergic asthma (mode)

5.57

3.62

5.2

2.9

—

Disturbance of activity and attention

2.68

3.60

6.2

5.1

—

Tooth agenesis EXCLUDE clefts and syndromes

4.02

3.59

4.8

6.4

—

Hypopituitarism

3.72

3.58

6.7

6.2

—

Haemolytic anaemias

7.81

3.56

7.0

4.9

—

Other disorders of adrenal gland

7.80

3.56

7.0

5.3

—

Other coagulation defects

7.79

3.56

2.1

3.6

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

7.79

3.55

3.3

2.9

—

Acute pancreatitis (for exclusion)

5.30

3.50

3.8

2.3

—

Use of pramipexole

6.16

3.50

1.4

2.2

—

Other and unspecified coagulation defects

10.02

3.50

1.8

4.0

—

Cardiomyopathy, other and unspecified

10.01

3.49

3.2

6.5

—

COPD-related respiratory insufficiency

10.01

3.49

1.0

—

117

2.21

3.49

4.1

4.8

—

Non-allergic asthma (mode), excluding more controls

5.25

3.47

5.2

2.8

—

Depression medications

6.47

3.45

3.4

3.9

—

Motor disorders, excluding more controls

4.22

3.44

5.5

6.4

—

Candidiasis

3.75

3.38

3.6

3.8

—

Phlebitis and thrombophlebitis (not including DVT)

5.00

3.36

1.2

1.6

—

Chronic gastritis

5.72

3.33

1.0

1.6

—

Procreative management

2.22

3.31

4.8

5.3

—

Nerve, nerve root and plexus disorders

2.17

3.29

1.5

2.2

—

Noninfectious colitis NAS

3.64

3.28

1.8

4.5

—

Other otitis externa (chronic)

8.59

3.26

4.7

3.1

—

Contraceptive management

2.81

3.24

2.3

1.4

—

Injury of muscle and tendon at wrist and hand level

4.74

3.23

1.1

2.3

—

Other skin changes

4.74

3.23

1.9

3.2

—

Psychiatric diseases

2.03

3.21

4.6

2.9

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.66

3.21

2.9

2.8

—

Noninfective enteritis and colitis

103

2.23

3.20

3.8

4.7

—

Disorders of synovium and tendon

2.70

3.19

3.0

2.3

—

Gastroduodenal ulcer

6.35

3.17

1.7

1.6

—

Coxibs

0.00

3.14

0.0

2.1

—

Pain in limb

112

1.97

3.12

4.0

3.7

—

Acute pancreatitis

4.50

3.11

3.8

2.3

—

Umbilical hernia

3.43

3.10

5.3

1.9

—

Heart failure and coronary heart disease

3.90

3.09

2.6

2.9

—

Chondropathies

4.00

3.08

4.3

2.6

—

Glaucoma suspect

4.00

3.08

1.6

1.4

—

Retention of urine

4.62

3.07

1.1

2.5

—

Fitting and adjustment of other devices

4.51

3.07

2.8

2.7

—

Pure hypercholesterolaemia

2.64

3.05

1.2

2.5

—

Acute lymphocytic leukaemia, helper endpoint

5.96

3.04

5.3

6.6

—

Acute lymphocytic leukaemia, including Hilmo

5.96

3.04

5.3

6.6

—

Acute lymphocytic leukaemia

5.96

3.04

5.3

6.6

—

Other CVD

5.83

3.02

2.6

—

Diseases of the digestive system

2.42

3.00

2.6

3.8

—

Cardiomyopathy

4.29

2.99

2.9

4.3

—

Other congenital malformations of upper alimentary tract

10.16

2.99

7.0

5.6

—

Amenorrhoea

10.01

2.98

1.4

3.2

—

Secondary uncertain malignant neoplasm

10.01

2.98

4.4

5.6

—

Cardiac murmurs and other cardiac sounds

2.86

2.96

7.7

5.8

—

Disease of hard tissues of teeth, NOS

4.36

2.95

1.7

1.6

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.85

2.93

5.4

5.7

—

Chronic periodontitis, complicated

2.72

2.93

1.7

1.3

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

4.75

2.92

4.4

6.0

—

Malnutrition

4.74

2.92

4.5

6.5

—

Abscess of anal and rectal regions

4.71

2.91

1.3

4.4

—

Asthma, unspecified (mode)

3.60

2.91

3.4

2.0

—

Asthma, unspecified (mode), excluding more controls

3.58

2.89

3.4

2.0

—

Osteoporosis

4.67

2.87

2.9

4.2

—

Other infectious diseases

6.67

2.86

2.5

4.1

—

Misadventures to patients during surgical and medical care

6.67

2.86

2.5

1.0

—

Infections with a predominantly sexual mode of transmission

3.15

2.84

1.4

1.8

—

Parasetamol

2.06

2.79

2.7

3.6

—

Disturbances of skin sensation

3.57

2.78

2.1

1.9

—

Anxiety (asthma-related co-morbidities)

2.06

2.76

3.6

3.3

—

Chronic periodontitis, including avohilmo

2.12

2.75

1.5

1.8

—

Specific development disorders of speech and language

2.54

2.75

7.1

6.4

—

Hypotension

8.34

2.75

1.6

1.0

—

Periodontitis

2.11

2.74

1.5

1.8

—

Unspecified privation

5.01

2.72

2.7

3.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

5.00

2.72

2.1

2.6

—

Nonischemic cardiomyopathy

5.00

2.72

1.6

4.8

—

Sequelae of external causes of morbidity and mortality

3.24

2.72

2.5

2.8

—

Missing teeth due to accident, extraction or parodontitis

2.52

2.71

2.0

1.9

—

Seborrhoeic dermatitis

6.01

2.70

4.3

4.1

—

Persons encountering health services in other circumstances

2.58

2.67

4.1

4.5

—

Mental retardation, excluding more controls

3.66

2.59

5.7

6.8

—

Sequelae with surgical and medical care as external cause

4.00

2.56

3.1

2.8

—

Visual disturbances

2.18

2.56

3.9

4.2

—

Mandibular retrognathia

3.05

2.55

9.1

5.6

—

Male infertility

7.16

2.55

2.6

1.7

—

Other osteochondropathies

7.15

2.55

5.8

2.9

—

Other infectious diseases

7.15

2.55

2.8

3.4

—

Hypokalaemia

7.15

2.55

5.2

3.9

—

Bronchitis, not specified as acute or chronic

7.15

2.55

1.6

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

7.15

2.55

4.4

4.7

—

Perforation of tympanic membrane

5.46

2.54

6.2

5.2

—

Continuous positive airway pressure

3.09

2.53

6.8

5.6

—

Other neurological diseases

2.15

2.50

2.2

2.8

—

Orchitis and epididymitis

4.38

2.47

3.1

3.8

—

Asthma, hospital admission 2, infections

134

1.90

2.44

4.1

4.4

—

Asthma-related infections

134

1.90

2.44

4.1

4.4

—

Other and unspecified iron deficiency

2.55

2.43

5.5

3.8

—

Acne

2.89

2.40

5.5

4.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

5.00

2.40

1.3

4.4

—

Nontraumatic intracranial haemmorrhage

5.00

2.40

2.8

1.9

—

Embedded teeth, including avohilmo

3.34

2.39

2.9

4.4

—

Hyperfunction of pituitary gland

6.26

2.37

3.0

4.5

—

Cerebral cysts

6.26

2.37

2.4

5.0

—

Melanocytic naevi, other sites/unspecified

6.26

2.37

2.6

3.5

—

Gout, strict definition

6.25

2.37

1.4

—

Adjustment and management of implanted device

6.25

2.37

1.0

4.3

—

Impacted cerumen

4.12

2.36

5.9

5.1

—

Mouth breathing

111

1.98

2.34

5.3

4.7

—

Hypothyroidism, strict autoimmune

2.28

2.33

1.9

3.3

—

Polyarthropathies

1.94

2.33

2.4

3.5

—

Ischaemic heart disease, wide definition

2.29

2.32

1.1

1.3

—

Emotional disorders starting during childhood or adolescence

2.49

2.31

5.4

6.3

—

Phobic anxiety disorders

3.21

2.30

4.0

3.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

112

1.96

2.29

3.4

4.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.02

2.28

2.1

1.9

—

Unspecified acute lower respiratory infection

2.94

2.28

3.6

3.3

—

Myocardial infarction

3.06

2.26

1.1

1.6

—

Conductive hearing loss, unspecified

3.89

2.25

5.9

4.7

—

Conjunctivitis (acute, non atopic)

2.06

2.24

4.6

5.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.07

2.24

2.3

3.1

—

Urticaria

2.15

2.24

6.6

4.4

—

Scissor bite

2.54

2.22

7.3

6.2

—

Sleep disorders (combined)

130

0.40

2.22

2.5

3.1

—

Juvenile osteochondrosis

5.57

2.21

4.6

4.2

—

Autoimmune diseases related-to ILD

127

1.82

2.20

2.8

3.1

—

Codeine or tramadol medication

1.90

2.19

1.6

1.3

—

Other disorders of glucose regulation and pancreatic internal secretion

3.34

2.18

2.1

5.6

—

Diaphragmatic hernia

3.33

2.17

1.4

1.7

—

Hyperkinetic disorders

2.08

2.16

6.2

5.8

—

Pain associated with micturition

4.29

2.15

4.2

5.9

—

Disorders of optic nerve and visual pathways

3.69

2.15

3.3

4.9

—

DVT of lower extremities and pulmonary embolism

2.99

2.13

2.1

1.2

—

Type 2 diabetes

2.01

2.11

1.3

1.6

—

Dermatitis and eczema

148

1.63

2.09

3.5

—

Congenital stenosis of pulmonary valve

5.07

2.08

6.4

6.2

—

Rosacea

5.00

2.07

4.2

2.2

—

Atrophic disorders of skin

5.00

2.07

5.4

4.1

—

Special screening examination for infectious and parasitic diseases

3.68

2.05

1.6

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.50

2.05

1.3

2.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.72

2.04

1.0

1.6

—

Convergent concomitant strabismus

4.01

2.04

3.8

6.0

—

Trigger finger

4.00

2.04

1.0

2.0

—

Isolated growth hormone deficiency

3.14

2.03

6.1

7.3

—

Hard cardiovascular diseases

107

1.73

2.02

2.7

4.3

—

Hyperplasia of prostate

2.84

2.02

1.0

—

Fracture of rib(s), sternum and thoracic spine

3.08

2.01

1.1

2.3

—

Other diseases of the digestive system

2.50

2.00

3.5

3.6

—

GI-bleeding

2.50

2.00

3.5

3.6

—

Major coronary heart disease event excluding revascularizations

2.50

2.00

1.2

1.5

—

Congenital malformations of the circulatory system

1.96

1.99

5.0

6.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

118

0.40

1.96

3.4

3.0

—

Triptan medication for migraine, single purchase ok

118

0.40

1.96

3.4

3.0

—

Asthma-related pneumonia

2.07

1.95

4.1

5.1

—

Other diseases of intestines

147

1.59

1.95

2.9

4.3

—

Pregnancy hypertension

2.78

1.94

1.0

1.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.35

1.94

3.9

4.2

—

Urticaria and erythema

1.98

1.94

6.3

4.4

—

Other complications of surgical and medical care, not elsewhere classified

4.55

1.94

2.8

2.1

—

Budesonide

4.55

1.94

1.0

1.5

—

Disorders of puberty, all

2.98

1.94

4.3

6.2

—

Early onset COPD, excluding more controls

4.54

1.94

1.0

—

Other soft tissue disorders, not elsewhere classified

120

1.66

1.93

3.9

—

Congenital deformities of feet

3.76

1.93

4.8

5.4

—

Other disorders of optic [2nd] nerve and visual pathways

3.76

1.93

3.5

5.5

—

Nail disorders

3.75

1.93

3.0

4.8

—

Other gastritis (incl. Duodenitis)

3.75

1.93

1.0

2.1

—

Pulmonary embolism

3.75

1.93

2.7

1.3

—

Pulmonary heart disease

3.75

1.93

2.7

1.3

—

Chronic diseases of tonsils and adenoids

135

1.64

1.93

5.0

3.8

—

Sleep disorders

116

0.37

1.93

1.7

2.7

—

Congenital malformations of heart and great arteries

1.96

1.89

4.6

6.4

—

Asthma, hospital admissions 3, pneumonia

2.05

1.89

4.1

5.0

—

Asthma-related pneumonia or sepsis

2.05

1.89

4.1

5.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.01

1.87

1.5

1.7

—

Acne vulgaris

2.86

1.86

5.0

4.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.81

1.86

2.0

2.4

—

Specific developmental disorder of motor function

2.41

1.85

5.5

7.1

—

Caries of dentine, including avohilmo

1.74

1.84

3.9

4.8

—

Disorders in reading

3.55

1.84

6.5

6.7

—

Haemorrhage from respiratory passages

2.30

1.83

2.7

3.9

—

Impacted teeth

2.15

1.83

5.7

4.4

—

Congenital deformities of feet

4.18

1.82

4.4

5.6

—

Pre-eclampsia

4.17

1.82

1.0

1.6

—

Pre-eclampsia or eclampsia

4.17

1.82

1.0

1.6

—

Percutaneous Coronary Intervention

100

1.72

1.82

2.4

4.2

—

Coronary revascularization (ANGIO or CABG)

100

1.71

1.81

2.4

4.2

—

Insomnia

114

0.38

1.79

1.7

2.3

—

Low back pain

0.36

1.79

1.4

2.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.76

1.79

1.5

2.4

—

Major coronary heart disease event

104

1.68

1.76

2.4

4.1

—

Other disorders of eyelid

2.52

1.74

1.3

2.6

—

Superficial injury of ankle and foot

2.50

1.73

5.3

5.2

—

Injuries to the thorax

2.22

1.73

1.4

2.2

—

Other systemic involvement of connective tissue

2.92

1.72

1.9

2.1

—

Visual impairment including blindness (binocular or monocular)

3.85

1.71

2.4

5.8

—

Dermatophytosis

3.85

1.71

3.2

2.5

—

Solid cancers, helper endpoint

1.80

1.68

3.0

3.1

—

Degeneration of macula and posterior pole

2.93

1.68

1.3

2.1

—

Sequelae of cerebrovascular disease

3.23

1.66

1.0

1.2

—

Mild mental retardation

3.17

1.66

5.5

5.2

—

Other and unspecified local infections of skin and subcutaneous tissue

3.16

1.66

5.2

4.5

—

Other local infections of skin and subcutaneous tissue

3.16

1.66

5.2

4.5

—

Soft tissue disorders related to use, overuse and pressure

3.16

1.66

2.0

1.2

—

Corneal ulcer

2.58

1.65

1.3

3.2

—

Lower back pain or/and sciatica

117

0.45

1.62

1.4

2.2

—

Motor disorders

2.25

1.62

5.5

7.2

—

Emergency coronary revascularization (for ACS)

103

1.65

1.62

2.4

4.1

—

Eustachian salpingitis and obstruction

3.57

1.61

5.0

2.9

—

Other diseases of pleura

2.37

1.60

2.0

3.5

—

Intestinal stricture

2.50

1.59

1.0

3.0

—

Oral corticosteroids

1.76

1.58

2.2

2.1

—

Functional dyspepsia

2.69

1.58

1.0

2.3

—

Soft tissue disorders

128

1.53

1.56

4.1

4.0

—

Artrosis, including avohilmo

0.37

1.56

2.0

1.4

—

Other systemic involvement of connective tissue (FG)

2.96

1.55

1.8

2.0

—

Inflammatory diseases of female pelvic organs

2.15

1.53

1.7

1.9

—

Diabetes, insulin treatment (Kela reimbursement)

109

1.61

1.52

1.5

3.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

104

1.62

1.52

1.5

4.0

—

Ventral hernia

3.33

1.52

5.6

1.4

—

Finngen Rheumatological endpoints

107

1.59

1.51

2.7

3.3

—

Heterophoria

2.86

1.50

5.2

6.5

—

Pulmonary heart disease, diseases of pulmonary circulation

2.86

1.50

2.7

2.1

—

Slow fetal growth and fetal malnutrition

2.88

1.50

3.7

6.5

—

Stroke, including SAH

2.05

1.48

1.8

1.5

—

Respiratory distress of newborn

2.08

1.47

5.4

6.9

—

Exposure to unspecified factor

167

1.51

1.46

2.9

4.1

—

Abnormal findings on diagnostic imaging of lung

2.40

1.46

1.4

1.8

—

Gastro-oesophageal reflux disease

1.78

1.46

1.9

3.6

—

Heart failure and bmi 25plus

3.38

1.45

1.0

1.3

—

Cardiovascular disorders originating in the perinatal period

3.19

1.44

5.6

—

Cerebrovascular diseases

1.87

1.44

2.2

2.0

—

Infections with a predominantly sexual mode of transmission

1.99

1.44

1.5

2.4

—

Acute lymphadenitis

3.13

1.44

5.8

4.9

—

Impacted maxillary molar

3.13

1.44

6.4

4.4

—

Cerebral palsy and other paralytic syndromes

2.73

1.43

3.5

4.3

—

Fracture of skull and facial bones

2.31

1.42

5.2

3.3

—

Persons encountering health services in circumstances related to reproduction

125

1.56

1.41

4.4

4.6

—

Open wound of lower leg

2.25

1.40

1.6

4.3

—

Anterior Iridocyclitis

2.41

1.39

1.6

2.6

—

Basal cell carcinoma

2.77

1.39

1.0

1.8

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.39

0.0

1.1

—

Basal cell carcinoma, including avohilmo

2.76

1.38

1.0

1.8

—

Other disorders of lacrimal gland

2.20

1.36

3.1

2.5

—

Diagnoses used for exclusion with ILD

2.61

1.36

4.0

1.9

—

Congenital malformations of pulmonary and tricuspid valves

2.97

1.36

6.4

7.1

—

Disorders of puberty

2.96

1.36

4.2

6.3

—

Other and unspecified injuries of lower leg

2.94

1.36

3.6

4.9

—

Syncope and collapse

2.40

1.35

1.0

2.0

—

Fracture of femur

2.59

1.34

2.3

3.8

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.87

1.34

6.1

4.6

—

Ischemic heart diseases

103

1.57

1.33

2.5

4.1

—

Contact with and exposure to communicable diseases

1.75

1.32

4.6

4.9

—

Other specified congenital malformation syndromes affecting multiple systems

2.51

1.30

3.5

7.5

—

Other intervertebral disc disorders

0.42

1.30

1.4

1.3

—

Other disorders of ear

119

1.54

1.29

5.0

3.6

—

Sleep apnoea, including avohilmo

102

0.49

1.28

2.6

2.2

—

Congenital deformities of hip

2.79

1.28

5.8

5.9

—

Congenital deformities of hip

2.79

1.28

5.8

5.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.57

1.28

1.0

1.8

—

Other disorders originating in the perinatal period

2.31

1.27

6.9

6.5

—

Other disorders of eye and adnexa

2.29

1.26

4.5

4.1

—

Abnormalities of gait and mobility

2.40

1.24

3.2

5.1

—

Acute and subacute iridocyclitis

2.40

1.24

1.7

2.4

—

Disorders of eyelid, lacrimal system and orbit

104

1.61

1.24

2.8

3.3

—

COPD related to multimorbidity

2.41

1.23

1.0

1.4

—

Diseases of male genital organs

1.56

1.22

5.0

4.6

—

Stroke, excluding SAH

2.01

1.21

2.0

1.6

—

Allergic urticaria

2.63

1.21

7.8

5.8

—

Retinal detachments and breaks

2.63

1.21

2.2

1.3

—

Fracture of shoulder and upper arm

1.79

1.20

2.6

4.4

—

Injury, poisoning and certain other consequences of external causes

1.64

1.19

4.5

4.9

—

Other degenerative diseases of the nervous system

2.67

1.19

1.4

1.0

—

Impetigo

2.31

1.18

5.3

6.3

—

Diabetes mellitus

113

1.50

1.18

1.7

4.0

—

Fissure and fistula of anal and rectal regions

2.31

1.18

3.0

1.6

—

Malignant neoplasm of digestive organs

2.63

1.18

4.0

1.9

—

Conductive and sensorineural hearing loss

1.61

1.18

5.2

3.1

—

Other diseases of anus and rectum

2.10

1.18

3.1

3.2

—

Other dorsopathies, not elsewhere classified

112

0.56

1.15

3.0

2.7

—

Non-selective monoamine reuptake inhibitors

0.00

1.15

0.0

1.3

—

Early onset COPD

2.50

1.15

1.0

2.3

—

Mixed specific developmental disorders

1.93

1.14

5.9

6.6

—

Mood disorders, excluding more controls

1.64

1.13

2.0

1.9

—

Conotruncal defects

2.35

1.12

6.0

6.7

—

Female genital prolapse

2.57

1.10

2.2

1.3

—

Myocardial infarction, strict

2.26

1.10

1.1

1.4

—

Diabetes medication

117

1.47

1.10

1.6

3.8

—

Right ventricular outflow tract obstruction

2.40

1.09

6.4

6.8

—

Biguanides

0.47

1.09

1.5

1.3

—

Hypoglycaemia, other or unspecified

2.38

1.09

1.6

6.0

—

Myocardial infarction, without ST-elevation

2.40

1.09

1.2

1.3

—

Disorders of conjunctiva

154

1.46

1.08

4.0

—

Colonic or urogenital fistula

2.19

1.08

3.4

1.7

—

Artificial joint operation, meniscal resection

0.47

1.08

1.5

1.6

—

Substance abuse, excluding more controls

1.83

1.07

1.5

1.6

—

Mycoses

140

1.49

1.04

3.4

3.2

—

Ischaemic Stroke, excluding all haemorrhages

1.97

1.04

1.6

1.7

—

Abnormal involuntary movements

2.27

1.03

2.0

3.5

—

Panic disorder

2.27

1.03

3.0

2.4

—

Follicular cysts of skin and subcutaneous tissue

2.27

1.03

2.2

2.4

—

Dysphagia

2.27

1.03

3.8

2.4

—

Iridocyclitis

2.06

1.02

1.6

3.0

—

Atopic dermatitis, strict definition with reimbursement

1.63

1.01

4.8

4.9

—

Malignant neoplasm of breast, including Hilmo

0.00

1.01

0.0

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

1.01

0.0

1.3

—

Disorders of speech understanding and production

1.89

1.01

7.0

—

Premature rupture of membranes

0.00

1.00

0.0

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.00

1.00

2.1

5.6

—

Congenital malformations of the respiratory system

2.18

0.98

4.4

5.8

—

Congenital malformations of the respiratory system

2.18

0.98

4.4

5.8

—

Hydrocele

2.17

0.98

5.4

4.6

—

Diabetes, varying definitions

114

1.44

0.98

1.7

4.0

—

Adverse effects, not elsewhere classified

1.85

0.96

5.2

4.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.96

0.0

2.2

—

Disorders of lacrimal system

1.85

0.95

2.9

3.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.69

0.95

3.9

4.5

—

Paracetamol or NSAID medication

0.47

0.94

3.2

5.4

—

Organic, including symptomatic, mental disorders

2.25

0.94

1.2

1.5

—

Non-invasive ventilation

2.23

0.93

5.8

4.4

—

Conjunctivitis

152

1.43

0.93

4.2

4.0

—

Transient ischemic attack

1.89

0.92

1.3

1.4

—

Neurological diseases

124

1.38

0.92

3.5

4.7

—

Fracture of foot, except ankle

1.73

0.92

5.0

3.5

—

Malignant neoplasm of skin

2.16

0.91

1.0

1.7

—

Ovarian cyst

2.16

0.91

1.5

1.6

—

Non-rheumatic valve diseases

1.73

0.90

3.6

4.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.75

0.90

5.5

3.8

—

Exclusion endpoint for clefts

2.07

0.89

3.5

7.0

—

Other and unspecified effects of external causes

1.69

0.88

5.1

4.4

—

Menorrhagia

2.08

0.88

2.2

1.6

—

COPD, hospital admissions

1.95

0.84

1.0

2.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

108

0.54

0.83

5.2

4.1

—

Other arthritis (FG)

1.74

0.82

3.5

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.81

0.0

1.6

—

COPD, early/later onset

1.87

0.81

1.0

2.0

—

Single delivery by forceps and vacuum extractor

0.00

0.81

0.0

1.6

—

Malignant neoplasm of breast, HER2-negative

0.00

0.80

0.0

1.3

—

Valvular heart disease excluding rheumatic fever

1.62

0.79

4.5

4.4

—

Combinations of oral blood glucose lowering drugs

0.00

0.79

0.0

1.2

—

Other chronic obstructive pulmonary disease

1.83

0.79

1.0

2.1

—

Malignant neoplasm of breast

0.00

0.79

0.0

1.3

—

Autism spe

0.00

0.78

0.0

5.7

—

Depression

122

1.39

0.77

2.0

2.9

—

Other and unspecified urticaria

1.70

0.75

5.9

4.6

—

Bacterial sepsis of newborn

2.11

0.75

8.4

6.8

—

Mood [affective] disorders

123

1.37

0.75

2.0

2.8

—

Angina pectoris

1.87

0.74

1.1

1.2

—

Paralytic ileus and intestinal obstruction

2.08

0.74

1.0

2.4

—

Mood disorders

123

1.37

0.74

2.0

2.8

—

1.54

0.74

1.9

2.2

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.84

0.73

3.1

6.7

—

Acute alcohol intoxication

1.84

0.73

2.3

2.5

—

Polyp of the female genital tract

2.05

0.73

1.6

—

Mental retardation, wide definition

1.63

0.73

5.7

7.0

—

Mental retardation

1.63

0.73

5.7

7.0

—

Aortic valve malfunction, age under 60 years

2.00

0.72

2.6

5.1

—

Other respiratory disorders and diseases

2.00

0.72

2.2

4.5

—

Other diseases of the respiratory system

2.00

0.72

2.2

4.5

—

Other congenital malformations

1.61

0.72

4.4

6.5

—

Pain in throat and chest

1.42

0.72

3.5

2.8

—

Vasomotor and allergic rhinitis

107

0.55

0.72

2.7

4.5

—

Cholelithiasis, broad definition with cholecystitis

1.54

0.72

2.4

1.6

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.97

0.72

1.4

1.2

—

Other specified/unspecified arthritis

1.75

0.71

3.4

3.7

—

Weight loss

1.92

0.70

7.4

4.9

—

5-aminosalicylic acid

1.92

0.70

5.0

3.2

—

Benign paroxysmal vertigo

1.92

0.70

1.2

2.1

—

Personality disorders, excluding more controls

1.92

0.70

2.0

1.5

—

Atopic dermatitis, strict definition

115

1.45

0.70

4.9

—

Spondylopathies

0.56

0.69

1.3

1.7

—

Gonarthrosis,primary

0.53

0.69

1.0

1.2

—

Undescended testicle

1.86

0.68

7.8

6.8

—

Pre-eclampsia or poor fetal growth

1.85

0.68

1.0

1.5

—

Lumbar disc prolapse

0.54

0.68

1.4

1.3

—

Hypothyroidism, other/unspecified

1.42

0.67

2.2

2.9

—

Pain in joint

1.49

0.67

2.5

3.5

—

Abnormalities of heart beat

1.63

0.67

3.1

2.7

—

Injuries to the elbow and forearm

134

1.38

0.67

3.7

4.0

—

Disorders of breast

1.63

0.66

1.9

1.7

—

Myopia

1.79

0.66

6.0

4.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.46

0.65

1.9

2.5

—

Other disorders of veins

1.78

0.65

1.0

1.3

—

Childhood allergy (age < 16)

1.45

0.65

4.7

5.8

—

Mental and behavioural disorders due to alcohol

1.54

0.65

1.8

2.3

—

Excessive earwax

1.47

0.63

6.0

3.6

—

Fracture of forearm

1.45

0.62

2.7

4.1

—

Injuries to the ankle and foot

153

1.34

0.62

4.9

3.5

—

Dorsalgia

108

0.69

0.61

2.6

2.7

—

Other/unspecified dorsalgia

1.62

0.61

3.5

2.7

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.38

0.60

2.2

2.9

—

Allergic contact dermatitis

0.00

0.60

0.0

3.5

—

Other disorders of patella

0.00

0.60

0.0

1.6

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.60

0.0

1.7

—

Dorsopathies

131

0.74

0.59

2.9

3.3

—

Other sexually transmitted chlamydial diseases

0.00

0.59

0.0

2.2

—

Prolonged pregnancy

0.00

0.59

0.0

1.6

—

Congenital malformations of genital organs

1.53

0.59

6.5

—

Transport accidents

1.45

0.59

3.5

—

Benign neoplasm of colon, rectum, anus and anal canal

1.51

0.58

1.1

1.2

—

Cardiodefibrillation

0.00

0.58

0.0

2.1

—

1.47

0.58

1.7

2.1

—

Acute alcohol intoxication, ICD10

1.71

0.57

2.3

2.6

—

Abnormal findings on examination of blood, without diagnosis

1.49

0.57

4.2

3.4

—

Sensorineural hearing loss

1.41

0.57

5.0

2.8

—

Congenital malformations of eye, ear, face and neck

1.67

0.56

4.2

6.4

—

Fall on same level involving ice and snow

0.57

0.56

3.0

2.9

—

COPD

1.63

0.56

1.0

2.1

—

Other arrhythmias

1.48

0.55

1.5

3.1

—

Appendectomy

1.44

0.55

2.5

2.0

—

Infections specific to the perinatal period

1.59

0.54

8.3

6.8

—

Other arthrosis

1.48

0.54

1.7

1.3

—

Leisure time condition

1.58

0.54

5.5

3.6

—

Abrasion of teeth

1.58

0.54

1.2

2.2

—

Type of accident

1.50

0.54

6.1

3.5

—

Other congenital malformations

1.48

0.53

4.4

6.2

—

Type 1 diabetes, definitions combined

1.47

0.53

2.3

6.2

—

Allergic colitis

1.54

0.53

8.7

6.2

—

Other disorders of penis

1.54

0.53

9.8

5.3

—

Type 1 diabetes, strict (exclude DM2)

1.45

0.53

2.3

6.1

—

Benign neoplasm: Colon

1.51

0.52

1.2

—

Asthma, hospital admissions , main diagnosis only

166

1.28

0.50

3.8

—

Sleep apnoea

0.69

0.49

2.5

2.2

—

Appendicitis, broad definition

1.37

0.49

1.9

2.0

—

Diseases of appendix

1.37

0.48

1.9

2.0

—

Redundant prepuce, phimosis and paraphimosis

1.51

0.48

6.4

4.2

—

Constipation

147

0.75

0.47

3.6

4.2

—

Gonarthrosis [arthrosis of knee](FG)

0.58

0.47

1.0

1.2

—

Dental pulpitis, including avohilmo

123

0.74

0.47

1.6

2.9

—

Disorders of the thyroid gland

100

1.30

0.46

2.2

2.7

—

Cholelithiasis

1.43

0.46

2.4

1.6

—

External causes of morbidity and mortality

1.30

0.46

4.4

4.5

—

Diverticular disease of intestine

1.48

0.45

1.3

1.2

—

Diseases of inner ear

1.38

0.44

1.3

1.7

—

Postmenopausal bleeding

0.00

0.43

0.0

1.3

—

Postmenopausal atrophic vaginitis

0.00

0.43

0.0

1.3

—

Allergic conjunctivitis

124

0.71

0.43

6.1

3.9

—

Urolithiasis

1.61

0.43

6.8

3.0

—

Fracture of lower leg, including ankle

1.38

0.42

3.5

3.4

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.65

0.42

5.7

3.8

—

Unspecific neurodegenerative disorder

0.00

0.42

0.0

1.1

—

D07AA Corticosteroids, weak (group I)

1.43

0.41

3.8

6.0

—

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

7.0

—

Irritable bowel syndrome

1.52

0.41

1.0

3.1

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.41

0.0

3.4

—

Ethmoidectomy

0.00

0.41

0.0

2.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.41

0.0

2.1

—

Malignant neoplasm of breast, HER-positive

0.00

0.41

0.0

1.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.41

0.0

1.2

—

Effects of foreign body entering through natural orifice

1.36

0.41

4.5

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.40

0.0

6.7

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.33

0.40

6.0

6.9

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.31

0.39

6.0

6.8

—

Dislocation, sprain and strain of joints and ligaments of knee

0.66

0.39

2.6

—

Non-allergic asthma

1.43

0.39

5.2

6.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.31

0.39

1.1

1.6

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.39

0.0

6.6

—

Mental and behavioural disorders due to psychoactive substance use

1.34

0.38

1.7

2.3

—

Arthropathies

126

1.21

0.38

3.1

4.1

—

Cholecystectomy

1.36

0.38

2.1

1.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.39

0.38

5.0

2.9

—

Cardiac arrhythmias

1.30

0.38

2.1

4.2

—

Meniscus derangement

1.32

0.38

1.9

1.1

—

Shoulder lesions

1.39

0.37

1.1

1.2

—

Gonarthrosis

0.65

0.37

1.0

1.1

—

Use of hypnotics and sedatives

102

1.24

0.36

1.9

2.9

—

Fracture at wrist and hand level

0.65

0.35

2.6

4.0

—

Obesity due to excess calories

0.64

0.35

1.8

3.7

—

Injuries to the knee and lower leg

145

1.19

0.35

2.7

3.7

—

Diseases of liver

1.40

0.35

2.2

2.6

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.37

0.34

1.7

1.2

—

Substance abuse

1.33

0.34

1.5

2.3

—

Injuries to the head

167

1.18

0.34

3.3

3.8

—

Obesity, other/unspecified

1.36

0.34

1.8

2.6

—

Dyspnoea

120

1.23

0.33

1.8

3.8

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.67

0.32

4.0

2.5

—

Type 2 diabetes, definitions combined, including avohilmo

0.70

0.32

1.6

1.5

—

Falls/tendency to fall

154

0.85

0.31

4.7

3.8

—

Congenital malformations of cardiac septa

1.35

0.31

3.4

7.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.29

0.30

1.7

1.5

—

Carpal tunnel syndrome

1.29

0.30

1.3

—

Atopic dermatitis

121

1.22

0.29

4.8

4.1

—

Rotator cuff syndrome

1.30

0.28

1.1

1.2

—

Injuries to the wrist and hand

160

1.17

0.28

1.7

4.0

—

Acute appendicitis

1.27

0.28

1.8

2.0

—

Diseases of pulp and periapical tissues, including avohilmo

135

0.84

0.28

2.0

4.1

—

Inflammatory bowel disease

1.27

0.27

3.6

3.8

—

Open wound of wrist and hand

1.27

0.27

1.4

3.3

—

Selective serotonin reuptake inhibitors

118

0.84

0.25

2.1

2.9

—

Episodal and paroxysmal disorders

158

0.87

0.25

3.4

4.1

—

Haemorrhagic and haematological disorders of fetus and newborn

1.20

0.25

5.7

6.6

—

Asthma/COPD (KELA code 203)

161

0.85

0.24

4.2

3.8

—

Other functional intestinal disorders

106

1.23

0.24

4.8

5.3

—

Type 2 diabetes, definitions combined

0.75

0.23

1.6

1.4

—

Type 2 diabetes, strict (exclude DM1)

0.73

0.23

1.6

1.4

—

Fall on and from stairs and steps

1.28

0.23

4.6

3.3

—

Personality disorders

1.28

0.23

2.0

1.8

—

Open wound of head

129

1.20

0.23

4.2

4.3

—

Disorders of vestibular function (Vertigo)

1.26

0.22

1.2

1.8

—

Necrosis of pulp, including avohilmo

0.76

0.22

1.1

2.4

—

Atrial septal defect

1.24

0.22

3.2

6.7

—

Alzheimer disease, including avohilmo

0.00

0.22

0.0

1.1

—

Postpartum care and examination

0.00

0.22

0.0

1.3

—

Use of anticholinesterases

0.00

0.21

0.0

1.1

—

N06DA Anticholinesterases

0.00

0.21

0.0

1.1

—

Congenital malformations of larynx

0.00

0.21

0.0

4.9

—

AV-block

0.00

0.21

0.0

4.5

—

Polyarthrosis

0.00

0.21

0.0

1.4

—

Other congenital malformations of skull and face bones

0.00

0.21

0.0

5.5

—

Complex cardiac defects

0.00

0.21

0.0

6.8

—

Disorder of the sleep-wake schedule

0.00

0.21

0.0

5.9

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

5.4

—

Burn and corrosion of wrist and hand

0.00

0.21

0.0

4.6

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.4

—

Foreign body in alimentary tract

0.00

0.21

0.0

5.0

—

Maltreatment syndromes

0.00

0.21

0.0

3.2

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.21

0.0

4.9

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

2.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

2.1

—

Recurrent dislocation and subluxation of joint

0.00

0.21

0.0

2.4

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

2.8

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

4.4

—

Psoriatic arthropathies

0.00

0.21

0.0

1.3

—

Cervicocranial syndrome

0.00

0.21

0.0

1.7

—

Acute and transient psychotic disorders

0.00

0.21

0.0

1.3

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.3

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.6

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Familial hypercholesterolemia

0.00

0.21

0.0

3.9

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.5

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.21

0.0

5.8

—

Autism spe, excluding more controls

0.00

0.21

0.0

6.3

—

Injury of unspecified body region

0.00

0.21

0.0

4.3

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

1.7

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.2

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.3

—

Alcohol use disorder, Swedish definition

1.26

0.21

1.5

1.8

—

Enterobiasis

0.00

0.21

0.0

6.9

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

3.2

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

3.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

3.2

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

3.8

—

Other eating disorders

0.00

0.21

0.0

4.9

—

Radiculopathy

0.00

0.21

0.0

1.3

—

Lichen planus, including avohilmo

0.00

0.21

0.0

1.4

—

Other disorders of amniotic fluid and membranes

0.00

0.20

0.0

1.3

—

Other symptoms and signs involving cognitive functions and awareness

1.27

0.20

1.8

2.2

—

Liveborn infants according to place of birth

0.00

0.20

0.0

6.1

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.20

0.0

6.6

—

Major anomalies of jaw size

0.00

0.20

0.0

5.6

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.20

0.0

5.8

—

Assault by bodily force

0.00

0.20

0.0

2.2

—

FESS (DNB20)

0.00

0.20

0.0

2.4

—

Primary coxarthrosis, bilateral

0.00

0.20

0.0

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

1.24

0.20

1.0

1.8

—

Other joint disorders

116

0.86

0.20

2.7

3.9

—

Ulcerative colitis

1.22

0.20

4.5

3.6

—

Congenital malformations of great arteries

1.16

0.19

3.0

7.2

—

Internal derangement of knee

1.15

0.19

2.0

2.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

139

0.87

0.18

2.9

3.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

119

1.15

0.18

2.3

2.7

—

Other external causes of accidental injury

109

0.87

0.17

3.9

4.0

—

Deforming dorsopathies

1.13

0.17

2.3

4.0

—

Injuries to the hip and thigh

1.19

0.16

2.3

3.7

—

Focal epilepsy

1.18

0.16

4.4

4.8

—

Temporomandibular joint disorders, including avohilmo

1.16

0.16

1.7

2.3

—

Acute appendicitis, no complications

1.21

0.16

2.0

—

Chronic apical periodontitis

106

1.13

0.15

1.4

2.9

—

Septal defects

1.14

0.15

3.7

6.8

—

Exclusions for E4_PCOS_CONSORTIUM

111

1.13

0.15

4.9

4.0

—

Obesity

103

0.84

0.13

1.9

3.3

—

Obesity and other hyperalimentation

103

0.84

0.13

1.9

3.3

—

Other antidepressants

0.90

0.11

2.1

2.2

—

Intracranial injury

128

0.89

0.10

4.2

4.3

—

IBD patients in KELA-register

1.09

0.09

5.0

3.4

—

Disorders of adult personality and behaviour

1.09

0.09

2.4

2.3

—

Other diseases of upper respiratory tract

141

1.07

0.09

4.9

3.7

—

Accidents

109

0.92

0.09

3.8

4.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.09

0.09

1.3

1.1

—

Asthma, including avohilmo

168

0.94

0.09

3.5

3.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.06

0.08

1.3

3.9

—

Depression or dysthymia

1.15

0.08

3.0

2.2

—

Dermatitis due to ingested food

0.77

0.08

5.8

6.6

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.77

0.08

1.0

3.7

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.03

0.08

7.3

6.7

—

Other fall from one level to another

0.86

0.07

3.0

5.4

—

Periapical abscess

0.85

0.07

1.9

3.4

—

Fall on same level

167

0.95

0.06

4.3

3.8

—

Injuries to the shoulder and upper arm

139

0.93

0.06

2.5

3.3

—

Epilepsy

1.11

0.05

4.2

5.2

—

Benzodiazepine use

111

0.93

0.05

1.8

2.2

—

Exposure to other specified factors

164

1.06

0.05

2.3

3.7

—

Migraine

0.92

0.04

3.0

3.9

—

Asthma (diagnoses ohter than nonallergic)

166

1.05

0.03

3.7

4.0

—

Dizziness and giddiness

0.92

0.03

2.0

2.5

—

Striking against or struck by other objects

103

1.07

0.01

2.6

4.6

—

Concussion

101

1.05

0.01

3.8

4.6

—

Other (not insulin) diabetes medications

0.94

0.00

1.6

1.4

—

Intracranial trauma

102

0.96

0.00

3.7

4.8

—

Other specific joint derangements/joint disorders

107

0.97

0.00

2.4

3.6

—

Unspecified fall

123

0.96

0.00

5.0

4.7

—

Other nutritional deficiencies

108

0.96

0.00

2.2

3.3

—

Chronic lower respiratory diseases

164

1.01

0.00

3.3

3.8

—

Dermatophytosis

1.02

0.00

2.5

3.0

—

Sudden idiopathic hearing loss

0.00

0.0

1.4

—

Pedal cyclist injured in transport accident

0.89

0.00

5.4

4.2

—

Digestive system disorders of fetus and newborn

0.00

0.0

6.3

—

Rheumatism, unspecified

0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

0.0

4.6

—

Lactose intolerance

0.00

0.0

4.8

—

Psoriatic arthropathies, ICD10

0.00

0.0

1.4

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

0.0

1.7

—

Certain zoonotic bacterial diseases

0.00

0.0

3.6

—

Medical abortion

0.99

0.00

1.7

—

0.00

0.0

1.5

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

2.5

—

Focal epilepsy, strict definition

0.98

0.00

4.3

4.7

—

Burns classified according to extent of body surface involved

0.00

0.0

3.7

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.2

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

2.4

—

Use of other anti-dementia drugs

0.00

0.0

1.1

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

Graves disease, strict definition

0.00

0.0

1.0

—

Nummular dermatitis

0.00

0.0

2.0

—

Use of memantine

0.00

0.0

1.1

—

Benign mammary dysplasia

0.00

0.0

1.1

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

2.4

—

Maxillary prognathism

0.00

-0.00

0.0

4.7

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

4.8

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.1

—

Alzheimer disease

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.8

—

Ulcerative proctitis

0.00

-0.00

0.0

3.4

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

4.3

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

4.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Alzheimer disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

5.4

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Other osteochondrodysplasias

0.00

-0.00

0.0

5.6

—

Scabies

0.93

-0.00

5.6

4.5

—

Alcohol use disorder, ICD-based

1.00

-0.00

1.2

1.6

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

5.0

—

Constitutional tall stature

0.00

-0.00

0.0

4.8

—

Raynaud syndrome

0.00

-0.00

0.0

1.7

—

Phakomatoses, not elsewhere classified

0.00

-0.00

0.0

6.3

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.2

—

Migraine without aura

0.88

-0.00

3.8

4.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

-0.00

0.0

6.2

—

Muscular dystrophy

0.00

-0.00

0.0

7.0

—

Injury of intra-abdominal organs

0.00

-0.00

0.0

4.7

—

Gender identity disorders

0.00

-0.00

0.0

4.3

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Other/unspecified rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.8

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

2.0

—

Ovarian dysfunction

0.00

-0.00

0.0

1.6

—

Other obstructed labour

0.00

-0.00

0.0

1.3

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

3.7

—

Inflammatory bowel disease, strict (require KELA)

0.96

-0.00

5.0

3.4

—

Other osteochondrodysplasias

0.00

-0.00

0.0

5.6

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

3.6

—

Alcoholic liver disease

0.00

-0.00

0.0

1.4

—

Other obstetric trauma

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

0.00

-0.00

0.0

4.6

—

Varicose veins of other sites

0.00

-0.00

0.0

3.0

—

0.00

-0.00

0.0

6.1

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

4.4

—

Multiple delivery

0.00

-0.00

0.0

1.3

—

Other perinatal haematological disorders

0.00

-0.00

0.0

5.4

—

Thiazolidinediones

0.00

-0.00

0.0

1.5

—

Uterine polyps

0.00

-0.00

0.0

1.2

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

2.4

—

Poor fetal growth

0.00

-0.00

0.0

1.6

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

-0.00

0.0

1.2

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Operations 1 for CAVS

0.00

-0.00

0.0

8.0

—

Twin gestation

0.00

-0.00

0.0

1.3

—

Other headache syndromes

0.88

-0.00

1.0

2.4

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

3.9

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

6.8

—

Amiodarone users

0.00

-0.00

0.0

1.5

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.8

—

Multiple gestation

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of breast, HER-negative

0.00

-0.00

0.0

1.2

—

Motorcycle rider injured in noncollision transport accidents

0.00

-0.00

0.0

3.3

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

6.0

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

6.1

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

4.8

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

4.0

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

6.2

—

Metatarsalgia

0.00

-0.00

0.0

2.4

—

Foreign body or object entering through skin

0.00

-0.00

0.0

3.4

—

Congenital malformations of lung

0.00

-0.00

0.0

4.8

—

Failed induction of labour

0.00

-0.00

0.0

1.7

—

Spermatocele

0.00

-0.00

0.0

2.3

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

6.0

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.6

—

Arthrosis

0.91

-0.00

1.6

1.3

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

4.1

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

5.4

—

Microcephaly

0.00

-0.00

0.0

4.6

—

Other and unspecified visual disturbances

0.00

-0.00

0.0

3.3

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

4.8

—

Obesity related asthma

1.00

-0.00

2.6

3.2

—

Congenital malformations of lung

0.00

-0.00

0.0

4.8

—

Lichen simplex chronicus and prurigo

0.00

-0.00

0.0

3.0

—

Other puerperal infections

0.00

-0.00

0.0

1.1

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

5.2

—

Memory loss

0.00

-0.00

0.0

1.0

—

Other congenital malformations of peripheral vascular system

0.00

-0.00

0.0

4.3

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

5.1

—

Lichen planus

0.00

-0.00

0.0

1.4

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Down's syndrome

0.00

-0.00

0.0

4.9

—

Other bursopathies

0.00

-0.00

0.0

2.3

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

-0.00

0.0

6.2

—

Unspecified jaundice

0.00

-0.00

0.0

5.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Reimbursement for rheumatic diseases

0.91

-0.00

4.4

3.7

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

3.2

—

Leiomyoma of uterus

0.91

-0.00

1.0

1.3

—

Neonatal jaundice from other and unspecified causes

0.95

-0.00

4.7

6.8

—

Type1 diabetes, definitions combined, early onset

1.00

-0.00

3.0

6.2

—

Benign neoplasm of eye and adnexa

0.00

-0.00

0.0

1.9

—

Fibrosis and cirrhosis of liver

0.00

-0.00

0.0

1.9

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.5

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.4

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Single ventricle heart

0.00

-0.00

0.0

7.6

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.5

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Aortic hypoplasia

0.00

-0.00

0.0

5.8

—

Superficial injury of lower leg

0.85

-0.00

2.0

3.7

—

Congenital malformations of great veins

0.00

-0.00

0.0

6.3

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

6.0

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

5.8

—

Pregnancy with abortive outcome

0.89

-0.00

1.3

1.7

—

Rubella [German measles]

0.00

-0.00

0.0

1.0

—

Polymyalgia rheumatica

0.00

-0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

-0.00

0.0

4.0

—

Pediculosis, acariasis and other infestations

0.86

-0.00

5.6

4.4

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS